N-((6-Chloropyridin-3-yl)methyl)ethanamine, 95.0%, 100mg

Chlorotrimethylphosphine gold(I), 95.0%, 1g

Moexipril hydrochloride, 98%, 250mg

(2-(N-Benzylsulfamoyl)-5-methylphenyl)boronic acid, 95.0%, 1g

(2-Amino-6-methylpyrimidin-4-ylthio)(diethylamino)methane-1-thione, 95.0%, 1g

tert-Butyl 5-oxo-5,7-dihydrospiro[cyclopenta[b]pyridine-6,4'-piperidine]-1'-carboxylate, 97%, 10g

Benzyl 4-((acetylthio)methyl)piperidine-1-carboxylate, 95.0%, 250mg

N-(4-FLUOROPHENYL)BENZENESULFONAMIDE, 95%, 50mg

3-Methylnonane>98.0%(GC)5mL

Dimethylsiloxane (60% propylene oxide - 40% ethylene oxide) block copolymers, 1,800 cSt, 100g

TERT-BUTYL 5-CHLORO-2-HYDROXYBENZYLCARBAMATE, 95%, 5g

tert-Butyl (4-fluoro-2-formylphenyl)carbamate, 95.0%, 100mg

(S)-N-((3-(3-Fluoro-4-(piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, 97%, 1g